Register for the 2023 SOSV Climate Tech Summit on Sept. 26-27.
Edward Painter

My position as CEO of A2A Pharmaceuticals allows me to build an extremely promising set of programs focused on new cancer and infectious disease medications.

My experience includes working for Salomon Brothers and Goldman Sachs for 3 years each as an analyst in research; six years as an institutional fixed income sales executive and 8 years in equity institutional sales with UBS focused on biotechnology.

Did you know?